FDA Investigator Paul E Stein

Paul E Stein has inspections in 12 countries as of 07 Nov 2023. Paul E Stein has collaborated with a combinined 4921 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
204
Last Inspection Date:
07 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
100005754
Country:
United States of America, Germany, Ireland, United Kingdom of Great Britain and Northern Ireland, France, Italy, Japan, Denmark, Finland, Netherlands, Sweden
Co-Investigator(s):
A Williams, Aaron L Dunbar, Abby E Pelletier, Althea A Williams, Amanda Dinaro, Amber D Brodas, Amber D Nair, Amy W Yan Mai, Andrea A Branche, Andrew J Garufi, Anissa M Vargas, Anita Narula, PhD, Ann B Okon, Ann Marie Montemurro, Anna M Alexander, Anthony C Warchut, Arduino Frankovic, Armen H Youssoufian, Arthur F Walker, Arthur G Hurst, Arthur S Williams, Jr, Benjamin J Dastoli, Benjamin W Anderson, Bill Tacket, Jr, Bo Chi, PhD, Brandy N Lepage, Brian J Ryan, Brian S Keefer, Bryan J Love, Byungja E Marciante, Calvin B Koerner, Carl A Huffman, III, Carl Lee, Carolyn J Cook, Cassandra L Abellard, Catherine J Laufmann, Catherine M Beer, Chad N Thomppson, Charisse K Green, Charles N Dupont, Christian Parra, Christine E Kelley, Christopher Janik, Chryste Best, Chryste D Best, Claudette D Brooks, D Jeany Argiropoulos, Dana A Razzano, Daniel J Lahar, Daniel L Aisen, Daniel T Lee, Daniel W Johnson, Darrell A Collins, Dave M Deroche, David J Gomes, David M Mcnew, David P Vanhouten, David R Delucia, Demitria J Argiropoulos, Demitria J Xiradakis, Denise D Dion, Denise L Terzian, Devaughn Edwards, Diamond M Oden, Diane C Thibodeau, Dianiris C Ayala, Dien N Nguyen, Dipesh K Shah, Donald C Obenhuber, PhD, Donald G Gordon, Dr. Nallaperumal Chidambaram, Dr. Robert C Horan, MD, Edmund F Mrak, Jr, Eduardo L Rodriguez, Edward J Janik, Elizabeth B Griffin, Elizabeth H Davis, Elizabeth H Slazak, Ellen M Landis, Eric J Reisenauer, Eric S Pittman, Erik W Koester, Erin L Nagel, Evelyn Taha, Fatima Bassa, Felix Maldonado, Frank J Marciniak, Frank Wackes, Frederic W French, III, Gam S Zamil, Geoffrey K Kilili, George G Calafactor, George T Allen, Jr, Gray, Gregson A Joseph, Harperd, Harry J Brewer, Helen B Ricalde, Hilary K Wagner, Jacqueline S Warner, James A Liubicich, James L Dunnie, Jr, James W Whitney, Jason A Rossi, Jeanette L Mcginnis, Jeffrey J Thibodeau, Jennifer Lalama, Jesse A Vazquez, Joel R Merriman, Joel R Powers, Joey V Quitania, Jogy George, John A Podsadowski, Jorge L Guadalupe, Joseph J Vannelli, Joseph Milcetic, Juan Rjimenez Garcia, Judy Keihl, Julie Scoma, Justine Tomasso, Karen L Kosar, Karen M Kondas, Karen R Smallwood, Katherine E Jacobitz, Kathryn A Nagy, Kelvin Cheung, Kenneth H Williams, Kent A Conforti, Kevin A Gonzalez, Kim M Downing, Kimberley A Ricketts, Kimberly Lewandowski Walker, Kimberly Y Smithson, Kinh Q Mac, Kwong P Lee, L Gnnmassimia Massimilla, PharmD, Laiza V Garcia, Lata C Mathew, PhD, Laura L Bechard, Lauren E Blaser, LCDR Chad N Thompson, LCDR Debra Emerson, LCDR Matthew J Morrison, Leena Thomas, Li Li, Lillie D Witcher, Lisa Mathew, Loretta Nemchik, Lori A Carr, Lori S Lawless, LT Luis O Rodriguez, Lydia S Chan, M Patriciaurphy Murphy, Marc S Neubauer, Marcia D Fields, Marcus F Yambot, Margaret E Sarles, Maribeth G Grattan, Maribeth G Niesen, Marie Elena C Puleo, Marie K Kinkade, Mark E Parmon, Mark R Mcclain, Mary F Finn, Mary M Finn, Maryam Tabatabaie, Matthew A Spataro, Matthew D Schnittker, Maura Rooney, Maya M Davis, Megan A Haggerty, Meghan L Fetterly, Meisha A Mandal, Melissa A Henaghan, Michael A Charles, Michael E Maselli, Michael G Mayfield, Michael G Sinkevich, Michael J Nerz, Michael J Sevka, MD, Michael P Sheehan, Michael P Sweeney, Michael R Dominick, Michael Shanks, MS, Michael W Burd, Michele L Obert, Michelle J Glembin, Mindy M Chou, Mra Davism, Nancy A Saxenian, Nancy A Saxenian Emmons, Nancy G Schmidt, Neal L Adams, Nicholas C Mendiola, Norman Wong, Nydia E Colon, Patricia A Clark, Patricia Fhughes Troost, Patrick C Klotzbuecher, Paul Mouris, Paula A Trost, Pauline N Logan, Perry T Nichols, Peter Abel, Peter M Trunk, Peter R Caparelli, Philip F Istafanos, DMV, MS, Philip H Lafleur, Prabhu P Raju, Preston M Lee, Rachel C Harrington, Rajiv R Srivastava, Ralph Jerndal, Raymond T Oji, Reba A Gates, Regina T Brown, Reyes Candau Chacon, PhD, Richard Jay Tucker, RS, Richard K Glabach, Richard K Vogel, Robert C Coleman, Robert J Veitch, Rodney D Combs, Ronald Ifraimov, Rosanna M Goodrich, Rose M Ashley, Roseline N Boateng, Ruben C Quintana, Russ E Davis, Russell J Glapion, Ruth Moore, PhD, Samina S Khan, Samuel K Gibbons, Jr, Samuel T Walker, Sara M Onyango, Sarah A Meehan, Satheesh Thomas, Scott R Izyk, Scott T Ballard, Seema S Singh, Seneca D Toms, Shafiq S Ahadi, Shirley J Berryman, Shreya Shah, Simone E Pitts, Sixto M Mercado Rios, Sony Mathews, Sripal R Mada, PhD, State Agency, Stephen C Smith, Stephen D Brown, Stephen D Eich, Stephen J Kilker, Stephen R Souza, Steven J Libal, Susan F Laska, MS, Syeda N Mahazabin, Tammy Notto, Tammy S Notto, Tanya R Syffrard, Tara K Carmody, Thao X Ta, Thomas J Mooney, Tyanna N Hadley, Uduak M Inokon, Unnee Ranjan, Valentino Fiorella, Virgilio F Pacio, CSO, Wanda J Torres, Wayne S Thompson, Wendy M Stone, William C Lubas, William M Rennells, Winston R Alejo, Xiaokuang Lai, PhD, Yehualashet A Gessesse, Yvette Mlacour Davis, Zhihao Qiu (Peter), PhD, Zhong Li, PhD

Paul E Stein's Documents

Publish Date Document Type Title
October, 2002 FDA 483 Response Dynarex Corporation - Form 483R, 2002-10-30
July, 2001 FDA 483 C.R. Bard Inc. - Form 483, 2001-07-13
April, 2003 EIR Isomedix Operations Inc. - EIR, 2003-04-30
September, 2001 EIR Purdue Pharma L.P. - EIR, 2001-09-21
January, 2012 FDA 483 Barr Laboratories Inc. - Form 483, 2012-01-13
June, 2000 EIR Medscand Medical Ab - EIR, 2000-06-29
October, 2002 EIR Dynarex Corporation - EIR, 2002-10-22
February, 2001 EIR Fidia Farmaceutici, S.p.A. - EIR, 2001-02-02
October, 2002 FDA 483 Dynarex Corporation - Form 483, 2002-10-22
November, 2009 FDA 483 Siemens Healthcare Diagnostics, Inc. - Form 483, 2009-11-24
November, 2001 FDA 483 Arrow International, Inc., Division of Teleflex Medical Inc. - Form 483, 2001-11-30
December, 2011 FDA 483 Siemens Healthcare Diagnostics, Inc. - Form 483, 2011-12-29
July, 2005 EIR Curia Global, Inc. - EIR, 2005-07-01
September, 2003 EIR Instrumentarium Dental, PaloDEx Group Oy - EIR, 2003-09-04
March, 2001 EIR Ortho Clinical Diagnostics - EIR, 2001-03-26
November, 2000 FDA 483 Mediware information Systems, Inc. - Form 483, 2000-11-01
January, 2003 EIR Hemocare Product Center - EIR, 2003-01-08
April, 2000 FDA 483 Carestream Health, Inc. - Form 483, 2000-04-13
March, 2003 EIR Smiths Medical International Ltd. - EIR, 2003-03-27
September, 2002 EIR Breonics, Inc. - EIR, 2002-09-05
August, 2009 FDA 483 Blenheim Pharmacal, Inc. - Form 483, 2009-08-17
January, 2003 FDA 483 Hemocare Product Center - Form 483, 2003-01-08
June, 2000 EIR Boston Scientific Limited - EIR, 2000-06-15
January, 2003 FDA 483 Response Hemocare Product Center - Form 483R, 2003-01-28
July, 2001 EIR C.R. Bard Inc. - EIR, 2001-07-13
September, 2003 FDA 483 Instrumentarium Dental, PaloDEx Group Oy - Form 483, 2003-09-04
September, 2001 FDA 483 Purdue Pharma L.P. - Form 483, 2001-09-21
November, 2001 EIR Arrow International, Inc., Division of Teleflex Medical Inc. - EIR, 2001-11-30
January, 2012 EIR Barr Laboratories Inc. - EIR, 2012-01-13

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more